Topiramate Tablet, Film Coated
Product Images NDC 82009-137

6 FDA label images from Quallent Pharmaceuticals Health Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 82009-137). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Quallent Pharmaceuticals Health Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structured Product Formula For Topiramate (B67db755 E8c2 45bd 8954 19dbdf1a77c5 01)

Structured Product Formula For Topiramate (B67db755 E8c2 45bd 8954 19dbdf1a77c5 01)
Chemical structure diagram of topiramate, showing its molecular arrangement with various carbon, oxygen, sulfur, nitrogen atoms and functional groups represented.*
FDA Label Image

Structured Product Formula For Topiramate (B67db755 E8c2 45bd 8954 19dbdf1a77c5 02)

Structured Product Formula For Topiramate (B67db755 E8c2 45bd 8954 19dbdf1a77c5 02)
A Kaplan-Meier survival curve chart showing cumulative rates for time to first seizure over 500 days for two Topiramate dosage groups: 50 mg/day (solid line) and 400 mg/day (dashed line). The chart compares seizure onset probability over time between the two dosage groups, with a p-value of 0.0002 indicating statistical significance.*
FDA Label Image

Topiramate Tablets Usp (B67db755 E8c2 45bd 8954 19dbdf1a77c5 03)

Topiramate Tablets Usp (B67db755 E8c2 45bd 8954 19dbdf1a77c5 03)
A bar chart showing the change from baseline to double-blind phase in average monthly migraine period rate with standard error for placebo and topiramate doses (50 mg/day, 100 mg/day, 200 mg/day) in two studies (Study 11 and Study 12). It compares mean reductions for each group, indicating statistical significance with p-values below 0.010 and 0.001 for higher doses.*
FDA Label Image

Topiramate Tablet-sl-25mg (B67db755 E8c2 45bd 8954 19dbdf1a77c5 04)

Topiramate Tablet-sl-25mg (B67db755 E8c2 45bd 8954 19dbdf1a77c5 04)
Label for Topiramate Tablets USP 25 mg by Quallent Pharmaceuticals Health LLC. The film-coated oral tablets package contains 500 tablets. The label includes dosing caution, storage instructions at 20°C to 25°C, moisture protection, and contact information for the manufacturer and medication guide availability.*
FDA Label Image

Topiramate Tablet-sl-25mg-60c (B67db755 E8c2 45bd 8954 19dbdf1a77c5 05)

Topiramate Tablet-sl-25mg-60c (B67db755 E8c2 45bd 8954 19dbdf1a77c5 05)
Topiramate 50 mg tablets, USP label from Quallent Pharmaceuticals Health LLC. The label states the package contains 500 tablets and includes storage instructions, dosage form as film-coated oral tablets, and manufacturer details referencing Zydus Lifesciences Ltd. This is a prescription-only human drug. The label also includes warnings to keep out of reach of children and to dispense the medication guide with the product.*
FDA Label Image

Topiramate Tablet-sl-100mg-60c (B67db755 E8c2 45bd 8954 19dbdf1a77c5 06)

Topiramate Tablet-sl-100mg-60c (B67db755 E8c2 45bd 8954 19dbdf1a77c5 06)
Topiramate 100 mg film-coated tablets packaging label from Quallent Pharmaceuticals Health LLC. The label indicates 500 tablets, oral route, with a clear statement of active ingredient strength. It includes storage instructions, a medication guide reference, and manufacturer details for Zydus Lifesciences Ltd., India, and Quallent Pharmaceuticals Health LLC, Grand Cayman. The label also features a barcode and a pharmacist dispensing note.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.